Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-23

Clinical Trial Update: Safety and Blood Level Study of Unit Dose Budesonide [Phase 1]

View source ↗

Summary

Phase 1 study of unit-dose budesonide in asthma assessed safety and blood levels; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

Sponsor: Allergan | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2013-10-23